BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 30364631)

  • 1. Synergistic effect of black tea polyphenol, theaflavin-3,3'-digallate with cisplatin against cisplatin resistant human ovarian cancer cells.
    Pan H; Li J; Rankin GO; Rojanasakul Y; Tu Y; Chen YC
    J Funct Foods; 2018 Jul; 46():1-11. PubMed ID: 30364631
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Theaflavin-3, 3'-digallate induces apoptosis and G2 cell cycle arrest through the Akt/MDM2/p53 pathway in cisplatin-resistant ovarian cancer A2780/CP70 cells.
    Tu Y; Kim E; Gao Y; Rankin GO; Li B; Chen YC
    Int J Oncol; 2016 Jun; 48(6):2657-65. PubMed ID: 27082635
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Theaflavin-3,3'-Digallate Enhances the Inhibitory Effect of Cisplatin by Regulating the Copper Transporter 1 and Glutathione in Human Ovarian Cancer Cells.
    Pan H; Kim E; Rankin GO; Rojanasakul Y; Tu Y; Chen YC
    Int J Mol Sci; 2018 Jan; 19(1):. PubMed ID: 29301278
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Theaflavin-3, 3'-digallate inhibits ovarian cancer stem cells via suppressing Wnt/β-Catenin signaling pathway.
    Pan H; Kim E; Rankin GO; Rojanasakul Y; Tu Y; Chen YC
    J Funct Foods; 2018 Nov; 50():1-7. PubMed ID: 30984291
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Theaflavin-3,3'-Digallate Suppresses Human Ovarian Carcinoma OVCAR-3 Cells by Regulating the Checkpoint Kinase 2 and p27 kip1 Pathways.
    Gao Y; Yin J; Tu Y; Chen YC
    Molecules; 2019 Feb; 24(4):. PubMed ID: 30769778
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibitory effect of black tea pigments, theaflavin‑3/3'-gallate against cisplatin-resistant ovarian cancer cells by inducing apoptosis and G1 cell cycle arrest.
    Pan H; Wang F; Rankin GO; Rojanasakul Y; Tu Y; Chen YC
    Int J Oncol; 2017 Nov; 51(5):1508-1520. PubMed ID: 29048667
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cisplatin-induced apoptosis proceeds by caspase-3-dependent and -independent pathways in cisplatin-resistant and -sensitive human ovarian cancer cell lines.
    Henkels KM; Turchi JJ
    Cancer Res; 1999 Jul; 59(13):3077-83. PubMed ID: 10397248
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Theaflavin-3,3'-digallate represses osteoclastogenesis and prevents wear debris-induced osteolysis via suppression of ERK pathway.
    Hu X; Ping Z; Gan M; Tao Y; Wang L; Shi J; Wu X; Zhang W; Yang H; Xu Y; Wang Z; Geng D
    Acta Biomater; 2017 Jan; 48():479-488. PubMed ID: 27838465
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Theaflavin-3, 3'-digallate decreases human ovarian carcinoma OVCAR-3 cell-induced angiogenesis via Akt and Notch-1 pathways, not via MAPK pathways.
    Gao Y; Rankin GO; Tu Y; Chen YC
    Int J Oncol; 2016 Jan; 48(1):281-92. PubMed ID: 26648098
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Theaflavin 3, 3'-Digallate Delays Ovarian Aging by Improving Oocyte Quality and Regulating Granulosa Cell Function.
    He J; Yao G; He Q; Zhang T; Fan H; Bai Y; Zhang J; Yang G; Xu Z; Hu J; Sun Y
    Oxid Med Cell Longev; 2021; 2021():7064179. PubMed ID: 34925699
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhancement of (-)-epigallocatechin-3-gallate and theaflavin-3-3'-digallate induced apoptosis by ascorbic acid in human lung adenocarcinoma SPC-A-1 cells and esophageal carcinoma Eca-109 cells via MAPK pathways.
    Gao Y; Li W; Jia L; Li B; Chen YC; Tu Y
    Biochem Biophys Res Commun; 2013 Aug; 438(2):370-4. PubMed ID: 23892041
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oridonin effectively reverses cisplatin drug resistance in human ovarian cancer cells via induction of cell apoptosis and inhibition of matrix metalloproteinase expression.
    Ma S; Tan W; Du B; Liu W; Li W; Che D; Zhang G
    Mol Med Rep; 2016 Apr; 13(4):3342-8. PubMed ID: 26935490
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiviral activity of theaflavin digallate against herpes simplex virus type 1.
    de Oliveira A; Prince D; Lo CY; Lee LH; Chu TC
    Antiviral Res; 2015 Jun; 118():56-67. PubMed ID: 25818500
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibitory Effects of the Four Main Theaflavin Derivatives Found in Black Tea on Ovarian Cancer Cells.
    Gao Y; Rankin GO; Tu Y; Chen YC
    Anticancer Res; 2016 Feb; 36(2):643-51. PubMed ID: 26851019
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Simultaneous Tests of Theaflavin-3,3'-digallate as an Anti-Diabetic Drug in Human Hepatoma G2 Cells and Zebrafish (
    Zhou H; Wu Y; Kim E; Pan H; He P; Li B; Chen YC; Tu Y
    Nutrients; 2021 Dec; 13(12):. PubMed ID: 34959930
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combination effect of adenovirus-mediated pro-apoptotic bax gene transfer with cisplatin or paclitaxel treatment in ovarian cancer cell lines.
    Tsuruta Y; Mandai M; Konishi I; Kuroda H; Kusakari T; Yura Y; Hamid AA; Tamura I; Kariya M; Fujii S
    Eur J Cancer; 2001 Mar; 37(4):531-41. PubMed ID: 11267864
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of the IGF signaling pathway reverses cisplatin resistance in ovarian cancer cells.
    Du J; Shi HR; Ren F; Wang JL; Wu QH; Li X; Zhang RT
    BMC Cancer; 2017 Dec; 17(1):851. PubMed ID: 29241458
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Theaflavin-3,3'-Digallate Plays a ROS-Mediated Dual Role in Ferroptosis and Apoptosis via the MAPK Pathway in Human Osteosarcoma Cell Lines and Xenografts.
    He T; Lin X; Yang C; Chen Z; Wang L; Li Q; Ma J; Zhan F; Wang Y; Yan J; Quan Z
    Oxid Med Cell Longev; 2022; 2022():8966368. PubMed ID: 36329803
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Theaflavin-3, 3'-Digallate Suppresses RANKL-Induced Osteoclastogenesis and Attenuates Ovariectomy-Induced Bone Loss in Mice.
    Ai Z; Wu Y; Yu M; Li J; Li S
    Front Pharmacol; 2020; 11():803. PubMed ID: 32694992
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Combined inhibition of PI3K and MEK has synergistic inhibitory effect on the proliferation of cisplatin-resistant ovarian cancer cells].
    Liu Y; Chen X; Luo Z
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2014 Jun; 30(6):592-6. PubMed ID: 24909280
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.